| Filing Date | Form | Description | Issuer | View |
|---|---|---|---|---|
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| 10-K/A |
Amendment to a previously filed 10-K |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| 10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Intellia Therapeutics, Inc. | ||
| 3 |
Initial filing by director officer or owner of more than ten percent. |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| SC 13D/A |
An amendment to a SC 13D filing |
Intellia Therapeutics, Inc. |
Displaying 421 - 430 of 587 results
Data provided by Kaleidoscope.